Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-029109
Filing Date
2025-02-27
Accepted
2025-02-27 16:30:28
Documents
6
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 atha_february_2025_s-8.htm S-8 217627
2 EX-5.1 atha-ex5_1.htm EX-5.1 13214
3 EX-23.1 atha-ex23_1.htm EX-23.1 3916
4 EX-FILING FEES atha-exfiling_fees.htm EX-FILING FEES 44736
5 GRAPHIC img222338278_0.jpg GRAPHIC 31040
6 GRAPHIC img222338278_1.jpg GRAPHIC 321697
  Complete submission text file 0000950170-25-029109.txt   766606
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285345 | Film No.: 25679567
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)